Healthcare & Life Sciences

Transform Operations, Embrace Technology, Leverage Data, and Manage Risk.

KPMG is guiding the Healthcare and Life Sciences industry in the transition from “volume to value” through advanced business transformation methodologies, coupled with our long-standing tax, audit and advisory services.

Our healthcare & life sciences capabilities 

We are a leading advisor to the Healthcare and Life Sciences industry, providing a wide range of Strategy, Advisory, Audit and Tax services to assist our clients grow their businesses, enhance performance, and manage risks. We offer a market-leading portfolio of methodologies, tools and services to assist our clients with: 

  • Transitioning from volume to value
  • Value-based growth strategies
  • Enhanced outcomes via advanced analytics
  • Pre- and post-deal planning and integration
  • Commercial and sales model transformation
  • Regulatory compliance
  • Realizing the value of healthcare IT and disruptive technologies
  • Optimizing global business services

Healthcare Providers Capabilities
Learn how KPMG can help.

Pharmaceutical Capabilities
Learn how KPMG can help.


Medical Device and Diagnostics Capabilities
Learn how KPMG can help.


Health Plans Capabilities
Learn how KPMG can help.


News & events

Stay informed of recent articles featuring thought leaders from KPMG's Healthcare and Life Sciences practice. Learn about upcoming events, webcasts and speaking engagements on the critical issues you face.


Hackers are getting much better at taking hospital networks for ransom
Business Insider |  March 31, 2016

KPMG's Media Healthcare Roundtable
Texas Business Radio |  March 17, 2016

PHI: Valuable and Vulnerable
For the Record |  March 2016

Watch How the Drug Overdose Epidemic Spread in America
Time |  March 16, 2016

Ash Shehata radio appearance
AM 1570 Minneapolis (Wellness Radio) |  March 9, 2016

The Power of Big Data
Pharmacy Practice News |  March 7, 2016

The Hacking Economy: Another Big Health Risk That Can Really Hurt You | February 18, 2016

An Introduction to Global Business Services for Medical Device Manufacturers
Med Device Online |  Feb 1, 2016

Industry Has Successfully ‘Transitioned’ to ICD-10: Leading Claims Firm
HFMA | January 15, 2016

Healthcare expected to drive big M&A activity again in 2016
Modern Healthcare | January 12, 2016

Reimbursement hurdles associated with biosimilars
Managed Healthcare Executive | January 1, 2016

For press inquiries, please contact Bill Borden, Corporate Communications

Our subject matter experts share insights on issues impacting the industry. View all recent Healthcare & Life Sciences Webcasts here.

Recent webcasts ondemand

Tune in to hear our partners’ perspectives on the issues and challenges you face during the industry transition from “volume to value.”

    Building a Healthier Organization: How Clinically-led, Quality-Driven Efforts Lead to Better Clinical and Financial Performance
    Jun 21, 2016 2:00 PM
    This webcast will focus on how clinically-led, quality-driven transformation can improve quality across the care continuum and can generate sustainable, long-term impact on both patient outcomes and financial performance. In addition, we will explore how taking a patient-centered approach can help organizations improve the patient’s journey through the care delivery continuum. Further, we will discuss methods to identify areas to embed leading practices in care delivery, limit unnecessary care variation, and enable smooth transitions into community care.

    Healthcare Transformation: Optimizing IT to drive “Value”
    May 5, 2016 1:00 PM
    Join us for our webcast to learn how an established framework can assist organizations in their IT transformations and implementation of value-based and population health management capabilities.

    Managing patient support program risks – Part II
    Apr 20, 2016 2:00 PM
    Join subject matter advisors from KPMG’s Life Sciences practice and the law firm of Morgan Lewis to understand how your organization can better understand regulatory considerations related to specific patient support program offerings, including copay assistance, product discounts, and adherence guidance.

    Virtual Care - Establishing a Scalable and Sustainable Program as a Growth Strategy
    Apr 14, 2016 2:00 PM
    The increasing demand in consumer and payer driven Telemedicine and Telehealth proof of concept projects continue to challenge many healthcare organizations. Optimizing and achieving economies of scale after initial pilot implementations or upgrades is critical to improving productivity, sustainability and patient engagement. Whether you have recently implemented a new pilot project or have had a program in place several for years, this webcast will focus on several key areas to help your organization extract greater value from Virtual Care services, including workflow inefficiencies, clinician adoption, changes in reimbursement and regulatory policy, and managing the cost of proprietary applications and systems integration. The issues discussed will be applicable to all providers interested in Virtual Care delivery models.

Our perspective

At KPMG, we believe that health plans, providers, pharmaceutical and medical device companies should be thinking beyond transformation. The larger issue is healthcare “convergence,” or operating in a more collaborative and integrated delivery model. The real question for forward-looking organizations is what role they plan to play in a more converged healthcare ecosystem.

We are not just business leaders, we are thought leaders. Read our most recent thought leadership here.


Who we are

KPMG is one of the largest providers of professional services to Healthcare and Life Sciences organizations globally. With more than 2,000 dedicated healthcare and life sciences professionals in the U.S., supported by a global network across 150 countries, we offer a market-leading portfolio of methodologies, tools and services.


We take a solutions-based approach to solving our clients’ most complex challenges. Our independence and objectivity ensures we make the best choices for our clients, and our multi-disciplinary approach allows us to take a 360-degree view of our clients’ challenges to help them understand the broader context of their business decisions. We focus on the horizon, not just the here and now, helping healthcare and life science organizations anticipate and prepare for tomorrow’s possibilities. 

This is why clients consistently choose KPMG.

Contact Ed Giniat

Ed Giniat

National Sector Leader
Healthcare & Life Sciences
Email    LinkedIn  

Contact Liam Walsh

Liam Walsh

Advisory Line of Business Leader
Healthcare & Life Sciences
Email    LinkedIn  

KPMG Healthcare Data and Analytics Survey Findings
Only 10% of Healthcare organizations use Data and Analytics to it’s potential.